Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task: Possible relevance to ADHD

Psychopharmacology

Volumn 230, Issue 1, 2013, Pages 89-111

  Bari, A ^a,b   Robbins, T W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Attention; Dopamine; Error monitoring; Impulsivity; Noradrenaline; Response inhibition; Rreaction time variability; Stop signal task

Indexed keywords

3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; ATIPAMEZOLE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; N [4 (2 CYANOPHENYL) 1 PIPERAZINYLMETHYL] 3 METHYLBENZAMIDE; NAFADOTRIDE; PRAZOSIN; PROPRANOLOL; SULPIRIDE;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ARTICLE; ATTENTION; BEHAVIOR; BIOLOGICAL MONITORING; COMPULSION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG MECHANISM; IMPULSIVENESS; MALE; MENTAL TASK; MOTIVATION; NEUROMODULATION; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; TASK PERFORMANCE;

ANIMALS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DOPAMINE; IMPULSIVE BEHAVIOR; MALE; MOTIVATION; NOREPINEPHRINE; PREFRONTAL CORTEX; RATS; REACTION TIME; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D3;

EID: 84886296015     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3141-6     Document Type: Article

References (245)

1. Adams ZW, Roberts WM, Milich R, Fillmore MT (2011) Does response variability predict distractibility among adults with attention-deficit/ hyperactivity disorder? Psychol Assess 23:427-436
2. Alexander JK, Hillier A, Smith RM, Tivarus ME, Beversdorf DQ (2007) Beta-adrenergic modulation of cognitive flexibility during stress. J Cogn Neurosci 19:468-478
3. Anden NE, Pauksens K, Svensson K (1982) Selective blockade of brain alpha 2-autoreceptors by yohimbine: effects on motor activity and on turnover of noradrenaline and dopamine. J Neural Transm 55:111-120
4. Antelman SM, Caggiula AR (1977) Norepinephrine-dopamine interactions and behavior. Science 195:646-653
5. Ariano MA, Wang J, Noblett KL, Larson ER, Sibley DR (1997) Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Res 752:26-34
6. Arnsten AF, Cai JX (1993) Postsynaptic alpha-2 receptor stimulation improves memory in aged monkeys: indirect effects of yohimbine versus direct effects of clonidine. Neurobiol Aging 14:597-603
7. Arnsten AF, Li BM (2005) Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57:1377-1384
8. Arnsten AF, Cai JX, Goldman-Rakic PS (1988) The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes. J Neurosci 8:4287-4298
9. Arnsten AF, Murphy B, Merchant K (2000) The selective dopamine D4 receptor antagonist, PNU-101387G, prevents stress-induced cognitive deficits in monkeys. Neuropsychopharmacology 23:405-410
10. Aron AR, Poldrack RA (2005) The cognitive neuroscience of response inhibition: relevance for genetic research in attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1285-1292
11. Aston-Jones G, Rajkowski J, Cohen J (2000) Locus coeruleus and regulation of behavioral flexibility and attention. Prog Brain Res 126:165-182
12. Baldwin RL, Chelonis JJ, Flake RA, Edwards MC, Feild CR, Meaux JB, Paule MG (2004) Effect of methylphenidate on time perception in children with attention-deficit/hyperactivity disorder. Exp Clin Psychopharmacol 12:57-64
13. Band GP, van der Molen MW, Logan GD (2003) Horse-race model simulations of the stop-signal procedure. Acta Psychol (Amst) 112:105-142
14. Bari A, Aston-Jones G (2013) Atomoxetine modulates spontaneous and sensory-evoked discharge of locus coeruleus noradrenergic neurons. Neuropharmacology 64:53-64
15. Bari A, Dalley JW, Robbins TW (2008) The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats. Nat Protoc 3:759-767
16. Bari A, Eagle DM, Mar AC, Robinson ES, Robbins TW (2009) Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats. Psychopharmacol (Berl) 205:273-283
17. Bari A, Mar AC, Theobald DE, Elands SA, Oganya KC, Eagle DM, Robbins TW (2011) Prefrontal and monoaminergic contributions to stop-signal task performance in rats. J Neurosci 31:9254-9263
18. Barik S, de Beaurepaire R (2005) Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat. Prog Neuropsychopharmacol Biol Psychiatry 29:718-726
19. Barry RJ, Clarke AR, Hajos M, McCarthy R, Selikowitz M, Bruggemann JM (2009) Acute atomoxetine effects on the EEG of children with attention-deficit/hyperactivity disorder. Neuropharmacology 57:702-707
20. Bellgrove MA, Mattingley JB, Hawi Z, Mullins C, Kirley A, Gill M, Robertson IH (2006) Impaired temporal resolution of visual attention and dopamine beta hydroxylase genotype in attention-deficit/hyperactivity disorder. Biol Psychiatry 60:1039-1045
21. Berger B, Tassin JP, Blanc G, Moyne MA, Thierry AM (1974) Histochemical confirmation for dopaminergic innervation of the rat cerebral cortex after destruction of the noradrenergic ascending pathways. Brain Res 81:332-337
22. Berridge CW, Espana RA (2000) Synergistic sedative effects of noradrenergic alpha(1)- and beta-receptor blockade on forebrain electroencephalographic and behavioral indices. Neuroscience 99:495-505
23. Berridge CW, Waterhouse BD (2003) The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 42:33-84
24. Berridge CW, Arnsten AF, Foote SL (1993) Noradrenergic modulation of cognitive function: clinical implications of anatomical, electrophysiological and behavioural studies in animal models. Psychol Med 23:557-564
25. Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B, Hamilton C, Spencer RC (2006) Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 60:1111-1120
26. Berridge CW, Shumsky JS, Andrzejewski ME, McGaughy JA, Spencer RC, Devilbiss DM, Waterhouse BD (2012) Differential sensitivity to psychostimulants across prefrontal cognitive tasks: differential involvement of noradrenergic alpha(1) - and alpha(2)-receptors. Biol Psychiatry 71:467-473
27. Bidwell LC, Willcutt EG, Defries JC, Pennington BF (2007) Testing for neuropsychological endophenotypes in siblings discordant for attention-deficit/hyperactivity disorder. Biol Psychiatry 62:991-998
28. Biederman J, Spencer T (1999) Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry 46:1234-1242
29. Blondeau C, Dellu-Hagedorn F (2007) Dimensional analysis of ADHD subtypes in rats. Biol Psychiatry 61:1340-1350
30. Boonstra AM, Kooij JJ, Oosterlaan J, Sergeant JA, Buitelaar JK (2005) Does methylphenidate improve inhibition and other cognitive abilities in adults with childhood-onset ADHD? J Clin Exp Neuropsychol 27:278-298
31. Botvinick MM, Braver TS, Barch DM, Carter CS, Cohen JD (2001) Conflict monitoring and cognitive control. Psychol Rev 108:624-652
32. Bouthenet ML, Souil E, Martres MP, Sokoloff P, Giros B, Schwartz JC (1991) Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res 564:203-219
33. Bowers MB Jr (1984) Homovanillic acid in caudate and pre-frontal cortex following neuroleptics. Eur J Pharmacol 99:103-105
34. Bradley C (1937) The behavior of children receiving benzedrine. Am J Psychiatry 9:577-585
35. Brown JW, Braver TS (2005) Learned predictions of error likelihood in the anterior cingulate cortex. Science 307:1118-1121
36. Brown DC 2nd, Co MS, Wolff RC, Atzori M (2012) alpha-Adrenergic receptors in auditory cue detection: alpha2 receptor blockade suppresses false alarm responding in the rat. Neuropharmacology 62:2178-2183
37. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27:699-711
38. Caine SB, Koob GF (1993) Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science 260:1814-1816
39. Caprioli D, Hong YT, Sawiak SJ, Ferrari V, Williamson DJ, Jupp B, Adrian Carpenter T, Aigbirhio FI, Everitt BJ, Robbins TW, Fryer TD, Dalley JW (2013) Baseline-dependent effects of cocaine pre-exposure on impulsivity and d receptor availability in the rat striatum: possible relevance to the attention-deficit hyperactivity syndrome. Neuropsychopharmacology
40. Carboni E, Silvagni A (2004) Dopamine reuptake by norepinephrine neurons: exception or rule? Crit Rev Neurobiol 16:121-128
41. Carr DB, Andrews GD, Glen WB, Lavin A (2007) alpha2-Noradrenergic receptors activation enhances excitability and synaptic integration in rat prefrontal cortex pyramidal neurons via inhibition of HCN currents. J Physiol 584:437-450
42. Carter CS, MacDonald AW 3rd, Ross LL, Stenger VA (2001) Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study. Am J Psychiatry 158:1423-1428
43. Castellanos FX, Tannock R (2002) Neuroscience of attention-deficit/ hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 3:617-628
44. Castellanos FX, Sonuga-Barke EJ, Milham MP, Tannock R (2006) Characterizing cognition in ADHD: beyond executive dysfunction. Trends Cogn Sci 10:117-123
45. Chamberlain SR, Muller U, Blackwell AD, Clark L, Robbins TW, Sahakian BJ (2006a) Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 311:861-863
46. Chamberlain SR, Muller U, Blackwell AD, Robbins TW, Sahakian BJ (2006b) Noradrenergic modulation of working memory and emotional memory in humans. Psychopharmacol (Berl) 188:397-407
47. Chamberlain SR, Del Campo N, Dowson J, Muller U, Clark L, Robbins TW, Sahakian BJ (2007) Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol Psychiatry 62:977-984
48. Chevrier A, Schachar RJ (2010) Error detection in the stop signal task. NeuroImage 53:664-673
49. Chevrier AD, Noseworthy MD, Schachar R (2007) Dissociation of response inhibition and performance monitoring in the stop signal task using event-related fMRI. Hum Brain Mapp 28:1347-1358
50. Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, Niznik HB, Levey AI (1995) The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 15:1714-1723
51. Colzato LS, van den Wildenberg WP, Van der Does AJ, Hommel B (2010) Genetic markers of striatal dopamine predict individual differences in dysfunctional, but not functional impulsivity. Neuroscience 170:782-788
52. Congdon E, Lesch KP, Canli T (2008) Analysis of DRD4 and DAT polymorphisms and behavioral inhibition in healthy adults: implications for impulsivity. Am J Med Genet B Neuropsychiatr Genet 147B:27-32
53. Coull JT, Sahakian BJ, Hodges JR (1996) The alpha(2) antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type. Psychopharmacol (Berl) 123:239-249
54. Coull JT, Jones ME, Egan TD, Frith CD, Maze M (2004) Attentional effects of noradrenaline vary with arousal level: selective activation of thalamic pulvinar in humans. NeuroImage 22:315-322
55. Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Laane K, Pena Y, Murphy ER, Shah Y, Probst K, Abakumova I, Aigbirhio FI, Richards HK, Hong Y, Baron JC, Everitt BJ, Robbins TW (2007) Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315:1267-1270
56. Daly SA, Waddington JL (1993) Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other «D-2-like» agonists. Neuropharmacology 32:509-510
57. Danielmeier C, Ullsperger M (2011) Post-error adjustments. Front Psychol 2:233
58. Darracq L, Blanc G, Glowinski J, Tassin JP (1998) Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of d-amphetamine. J Neurosci 18:2729-2739
59. de Bruijn ER, Hulstijn W, Verkes RJ, Ruigt GS, Sabbe BG (2004) Drug-induced stimulation and suppression of action monitoring in healthy volunteers. Psychopharmacol (Berl) 177:151-160
60. De Martino B, Strange BA, Dolan RJ (2008) Noradrenergic neuromodulation of human attention for emotional and neutral stimuli. Psychopharmacol (Berl) 197:127-136
61. De Sarro GB, Ascioti C, Froio F, Libri V, Nistico G (1987) Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms. Br J Pharmacol 90:675-685
62. de Wit H, Enggasser JL, Richards JB (2002) Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 27:813-825
63. Depoortere R, Perrault G, Sanger DJ (1996) Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine. Psychopharmacol (Berl) 124:231-240
64. Depoortere R, Perrault G, Sanger DJ (1999) Intracranial self-stimulation under a progressive-ratio schedule in rats: effects of strength of stimulation, d-amphetamine, 7-OH-DPAT and haloperidol. Psychopharmacol (Berl) 142:221-229
65. Devauges V, Sara SJ (1990) Activation of the noradrenergic system facilitates an attentional shift in the rat. Behav Brain Res 39:19-28
66. Devoto P, Flore G, Pani L, Gessa GL (2001) Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol Psychiatry 6:657-664
67. Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE (2005) Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 62:1377-1381
68. Drouin C, Blanc G, Villegier AS, Glowinski J, Tassin JP (2002) Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of d-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics. Synapse 43:51-61
69. Duarte C, Biala G, Le Bihan C, Hamon M, Thiebot MH (2003a) Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats. Psychopharmacol (Berl) 166:19-32
70. Duarte C, Lefebvre C, Chaperon F, Hamon M, Thiebot MH (2003b) Effects of a dopamine D3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats. Neuropsychopharmacology 28:1903-1915
71. Durston S, Fossella JA, Casey BJ, Hulshoff Pol HE, Galvan A, Schnack HG, Steenhuis MP, Minderaa RB, Buitelaar JK, Kahn RS, van Engeland H (2005) Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls. Mol Psychiatry 10:678-685
72. Eagle DM, Robbins TW (2003) Inhibitory control in rats performing a stop-signal reaction-time task: effects of lesions of the medial striatum and d-amphetamine. Behav Neurosci 117:1302-1317
73. Eagle DM, Tufft MR, Goodchild HL, Robbins TW (2007) Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol. Psychopharmacol (Berl) 192:193-206
74. Eagle DM, Bari A, Robbins TW (2008) The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacol (Berl) 199:439-456
75. Eagle DM, Wong JC, Allan ME, Mar AC, Theobald DE, Robbins TW (2011) Contrasting roles for dopamine D1 and D2 receptor subtypes in the dorsomedial striatum but not the nucleus accumbens core during behavioral inhibition in the stop-signal task in rats. J Neurosci 31:7349-7356
76. Epstein JN, Conners CK, Hervey AS, Tonev ST, Arnold LE, Abikoff HB, Elliott G, Greenhill LL, Hechtman L, Hoagwood K, Hinshaw SP, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Wells K, Vitiello B, Wigal T (2006) Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiatry 47:446-456
77. Epstein JN, Brinkman WB, Froehlich T, Langberg JM, Narad ME, Antonini TN, Shiels K, Simon JO, Altaye M (2011) Effects of stimulant medication, incentives, and event rate on reaction time variability in children Wwith ADHD. Neuropsychopharmacology 36(5):1060-1072
78. Everitt BJ, Robbins TW (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8:1481-1489
79. Falkenstein M, Hoormann J, Christ S, Hohnsbein J (2000) ERP components on reaction errors and their functional significance: a tutorial. Biol Psychol 51:87-107
80. Faraone SV, Doyle AE, Mick E, Biederman J (2001) Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 158:1052-1057
81. Fernandez-Pastor B, Mateo Y, Gomez-Urquijo S, Javier Meana J (2005) Characterization of noradrenaline release in the locus coeruleus of freely moving awake rats by in vivo microdialysis. Psychopharmacol (Berl) 180:570-579
82. Fernando AB, Economidou D, Theobald DE, Zou MF, Newman AH, Spoelder M, Caprioli D, Moreno M, Hipolito L, Aspinall AT, Robbins TW, Dalley JW (2012) Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists. Psychopharmacol (Berl) 219:341-352
83. Fitzpatrick PA, Klorman R, Brumaghim JT, Borgstedt AD (1992) Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder. J Am Acad Child Adolesc Psychiatry 31:226-234
84. Flietstra RJ, Levant B (1998) Comparison of D2 and D3 dopamine receptor affinity of dopaminergic compounds in rat brain. Life Sci 62:1825-1831
85. Frank MJ, Santamaria A, O'Reilly RC, Willcutt E (2007) Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder. Neuropsychopharmacology 32:1583-1599
86. Franowicz JS, Arnsten AF (1998) The alpha-2a noradrenergic agonist, guanfacine, improves delayed response performance in young adult rhesus monkeys. Psychopharmacol (Berl) 136:8-14
87. Gehring WJ, Goss B, Coles MGH, Meyers DE, Donchin E (1993) A neural system for error detection and compensation. Psychol Sci 4:385-390
88. Gerlach M, Double K, Arzberger T, Leblhuber F, Tatschner T, Riederer P (2003) Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum. J Neural Transm 110:1119-1127
89. Gilmour G, Arguello A, Bari A, Brown VJ, Carter C, Floresco SB, Jentsch DJ, Tait DS, Young JW, Robbins TW (2012) Measuring the construct of executive control in schizophrenia: defining and validating translational animal paradigms for discovery research. Neurosci Biobehav Rev
90. Gioanni Y, Thierry AM, Glowinski J, Tassin JP (1998) Alpha1-adrenergic, D1, and D2 receptors interactions in the prefrontal cortex: implications for the modality of action of different types of neuroleptics. Synapse 30:362-370
91. Gobert A, Rivet JM, Cistarelli L, Melon C, Millan MJ (1997) Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats. J Neurochem 69:2616-2619
92. Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160:636-645
93. Grandoso L, Pineda J, Ugedo L (2004) Comparative study of the effects of desipramine and reboxetine on locus coeruleus neurons in rat brain slices. Neuropharmacology 46:815-823
94. Granon S, Passetti F, Thomas KL, Dalley JW, Everitt BJ, Robbins TW (2000) Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 20:1208-1215
95. Gresch PJ, Sved AF, Zigmond MJ, Finlay JM (1995) Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem 65:111-116
96. Guyon A, Assouly-Besse F, Biala G, Puech AJ, Thiebot MH (1993) Potentiation by low doses of selected neuroleptics of food-induced conditioned place preference in rats. Psychopharmacol (Berl) 110:460-466
97. Haapalinna A, Viitamaa T, MacDonald E, Savola JM, Tuomisto L, Virtanen R, Heinonen E (1997) Evaluation of the effects of a specific alpha 2-adrenoceptor antagonist, atipamezole, on alpha 1- and alpha 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine. Naunyn Schmiedebergs Arch Pharmacol 356:570-582
98. Haapalinna A, Sirvio J, Lammintausta R (1998) Facilitation of cognitive functions by a specific alpha2-adrenoceptor antagonist, atipamezole. Eur J Pharmacol 347:29-40
99. Haapalinna A, Sirvio J, MacDonald E, Virtanen R, Heinonen E (2000) The effects of a specific alpha(2)-adrenoceptor antagonist, atipamezole, on cognitive performance and brain neurochemistry in aged Fisher 344 rats. Eur J Pharmacol 387:141-150
100. Hahn B, Stolerman IP (2005) Modulation of nicotine-induced attentional enhancement in rats by adrenoceptor antagonists. Psychopharmacol (Berl) 177:438-447
101. Hausknecht KA, Acheson A, Farrar AM, Kieres AK, Shen RY, Richards JB, Sabol KE (2005) Prenatal alcohol exposure causes attention deficits in male rats. Behav Neurosci 119:302-310
102. Hazell PL, Kohn MR, Dickson R, Walton RJ, Granger RE, Wyk GW (2011) Core ADHD symptom improvement with atomoxetine versus methylphenidate: a direct comparison meta-analysis. J Atten Disord 15:674-683
103. Heidbreder CA, Newman AH (2010) Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders. Ann N Y Acad Sci 1187:4-34
104. Helms CM, Gubner NR, Wilhelm CJ, Mitchell SH, Grandy DK (2008) D4 receptor deficiency in mice has limited effects on impulsivity and novelty seeking. Pharmacol Biochem Behav 90:387-393
105. Hess C, Reif A, Strobel A, Boreatti-Hummer A, Heine M, Lesch KP, Jacob CP (2009) A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders. J Neural Transm 116:121-130
106. Hester R, Nandam LS, O'Connell RG, Wagner J, Strudwick M, Nathan PJ, Mattingley JB, Bellgrove MA (2012) Neurochemical enhancement of conscious error awareness. J Neurosci 32:2619-2627
107. Holmes J, Payton A, Barrett J, Harrington R, McGuffin P, Owen M, Ollier W, Worthington J, Gill M, Kirley A, Hawi Z, Fitzgerald M, Asherson P, Curran S, Mill J, Gould A, Taylor E, Kent L, Craddock N, Thapar A (2002) Association of DRD4 in children with ADHD and comorbid conduct problems. Am J Med Genet 114:150-153
108. Holroyd CB, Coles MG (2002) The neural basis of human error processing: reinforcement learning, dopamine, and the error-related negativity. Psychol Rev 109:679-709
109. Jakala P, Sirvio J, Riekkinen P Jr, Haapalanna A, Riekkinen P (1992) Effects of atipamezole, an alpha 2-adrenoceptor antagonist, on the performance of rats in a five-choice serial reaction time task. Pharmacol Biochem Behav 42:903-907
110. Jentsch JD, Taylor JR, Redmond DE Jr, Elsworth JD, Youngren KD, Roth RH (1999) Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys. Psychopharmacol (Berl) 142:78-84
111. Jentzsch I, Dudschig C (2009) Why do we slow down after an error? Mechanisms underlying the effects of posterror slowing. Q J Exp Psychol (Hove) 62:209-218
112. Ji XH, Ji JZ, Zhang H, Li BM (2008) Stimulation of alpha2-adrenoceptors suppresses excitatory synaptic transmission in the medial prefrontal cortex of rat. Neuropsychopharmacology 33:2263-2271
113. Jones CR, Malone TJ, Dirnberger G, Edwards M, Jahanshahi M (2008) Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease. Brain Cogn 68:30-41
114. Kaiser S, Roth A, Rentrop M, Friederich HC, Bender S, Weisbrod M (2008) Intra-individual reaction time variability in schizophrenia, depression and borderline personality disorder. Brain Cogn 66:73-82
115. Kaneno S, Komatsu H, Fukamauchi F, Ikawa K, Watanabe A (1991) Biochemical basis of antidepressant effect of low dose of sulpiride. Jpn J Psychiatry Neurol 45:131-132
116. Kaneno S, Fukamauchi F, Komatsu H, Koyama K, Ikawa K (2001) Reversal effect of sulpiride on rotational behaviour of rats with unilateral frontal cortex ablation: an alternative explanation for the pharmacological mechanism of its antidepressant effect. Behav Pharmacol 12:69-73
117. Karami M, Zarrindast MR (2008) Morphine sex-dependently induced place conditioning in adult Wistar rats. Eur J Pharmacol 582:78-87
118. Kattoulas E, Evdokimidis I, Stefanis NC, Avramopoulos D, Stefanis CN, Smyrnis N (2010) Monitoring antisaccades: inter-individual differences in cognitive control and the influence of COMT and DRD4 genotype variations. Exp Brain Res 203:453-463
119. Kelley BJ, Yeager KR, Pepper TH, Beversdorf DQ (2005) Cognitive impairment in acute cocaine withdrawal. Cogn Behav Neurol 18:108-112
120. Kelley BJ, Yeager KR, Pepper TH, Bornstein RA, Beversdorf DQ (2007) The effect of propranolol on cognitive flexibility and memory in acute cocaine withdrawal. Neurocase 13:320-327
121. Kerns JG, Cohen JD, MacDonald AW 3rd, Cho RY, Stenger VA, Carter CS (2004) Anterior cingulate conflict monitoring and adjustments in control. Science 303:1023-1026
122. Khroyan TV, Fuchs RA, Baker DA, Neisewander JL (1997) Effects of D3-preferring agonists 7-OH-PIPAT and PD-128,907 on motor behaviors and place conditioning. Behav Pharmacol 8:65-74
123. Kieling C, Genro JP, Hutz MH, Rohde LA (2008) The -1021 C/T DBH polymorphism is associated with neuropsychological performance among children and adolescents with ADHD. Am J Med Genet B Neuropsychiatr Genet 147B:485-490
124. Klein C, Wendling K, Huettner P, Ruder H, Peper M (2006) Intra-subject variability in attention-deficit hyperactivity disorder. Biol Psychiatry 60:1088-1097
125. Koffarnus MN, Newman AH, Grundt P, Rice KC, Woods JH (2011) Effects of selective dopaminergic compounds on a delay-discounting task. Behav Pharmacol 22:300-311
126. Kohler C, Haglund L, Ogren SO, Angeby T (1981) Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies. J Neural Transm 52:163-173
127. Kollins SH, Anastopoulos AD, Lachiewicz AM, FitzGerald D, Morrissey-Kane E, Garrett ME, Keatts SL, Ashley-Koch AE (2008) SNPs in dopamine D2 receptor gene (DRD2) and norepinephrine transporter gene (NET) are associated with continuous performance task (CPT) phenotypes in ADHD children and their families. Am J Med Genet B Neuropsychiatr Genet 147B:1580-1588
128. Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278:52-58
129. Korenblum CB, Chen SX, Manassis K, Schachar RJ (2007) Performance monitoring and response inhibition in anxiety disorders with and without comorbid ADHD. Depress Anxiety 24:227-232
130. Koskinen T, Sirvio J (2001) Studies on the involvement of the dopaminergic system in the 5-HT2 agonist (DOI)-induced premature responding in a five-choice serial reaction time task. Brain Res Bull 54:65-75
131. Kramer UM, Cunillera T, Camara E, Marco-Pallares J, Cucurell D, Nager W, Bauer P, Schule R, Schols L, Rodriguez-Fornells A, Munte TF (2007) The impact of catechol-O-methyltransferase and dopamine D4 receptor genotypes on neurophysiological markers of performance monitoring. J Neurosci 27:14190-14198
132. Kuczenski R, Segal DS (2002) Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 22:7264-7271
133. Lacroix LP, Hows ME, Shah AJ, Hagan JJ, Heidbreder CA (2003) Selective antagonism at dopamine D3 receptors enhances monoaminergic and cholinergic neurotransmission in the rat anterior cingulate cortex. Neuropsychopharmacology 28:839-849
134. LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, Kennedy JL (1996) Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1:121-124
135. Lanau F, Zenner MT, Civelli O, Hartman DS (1997) Epinephrine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor. J Neurochem 68:804-812
136. Langley K, Marshall L, van den Bree M, Thomas H, Owen M, O'Donovan M, Thapar A (2004) Association of the dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. Am J Psychiatry 161:133-138
137. Lapiz MD, Morilak DA (2006) Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 137:1039-1049
138. Lee SH, Shin DW, Stein MA (2010) Increased cortisol after stress is associated with variability in response time in ADHD children. Yonsei Med J 51:206-211
139. Leth-Steensen C, Elbaz ZK, Douglas VI (2000) Mean response times, variability, and skew in the responding of ADHD children: a response time distributional approach. Acta Psychol (Amst) 104:167-190
140. Levant B, Vansell NR (1997) In vivo occupancy of D2 dopamine receptors by nafadotride. Neuropsychopharmacology 17:67-71
141. Li CS, Milivojevic V, Kemp K, Hong K, Sinha R (2006a) Performance monitoring and stop signal inhibition in abstinent patients with cocaine dependence. Drug Alcohol Depend 85:205-212
142. Li J, Wang Y, Zhou R, Zhang H, Yang L, Wang B, Faraone SV (2006b) Association between tryptophan hydroxylase gene polymorphisms and attention deficit hyperactivity disorder in Chinese Han population. Am J Med Genet B Neuropsychiatr Genet 141B:126-129
143. Li CS, Yan P, Chao HH, Sinha R, Paliwal P, Constable RT, Zhang S, Lee TW (2008) Error-specific medial cortical and subcortical activity during the stop signal task: a functional magnetic resonance imaging study. Neuroscience 155:1142-1151
144. Lijffijt M, Kenemans JL, Verbaten MN, van Engeland H (2005) A meta-analytic review of stopping performance in attention-deficit/hyperactivity disorder: deficient inhibitory motor control? J Abnorm Psychol 114:216-222
145. Lijffijt M, Kenemans JL, ter Wal A, Quik EH, Kemner C, Westenberg H, Verbaten MN, van Engeland H (2006) Dose-related effect of methylphenidate on stopping and changing in children with attention-deficit/hyperactivity disorder. Eur Psychiatry 21:544-547
146. Lindvall O, Bjorklund A (1974) The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta Physiol Scand Suppl 412:1-48
147. Lipszyc J, Schachar R (2010) Inhibitory control and psychopathology: a meta-analysis of studies using the stop signal task. J Int Neuropsychol Soc 16:1064-1076
148. Liu YP, Lin YL, Chuang CH, Kao YC, Chang ST, Tung CS (2009) Alpha adrenergic modulation on effects of norepinephrine transporter inhibitor reboxetine in five-choice serial reaction time task. J Biomed Sci 16:72
149. Logan GD (1994) On the ability to inhibit thought and action. A users' guide to the stop signal paradigm. In: Dagenbach D, Carr TH (eds) Inhibitory processes in attention, memory and language. Academic Press, San Diego, CA, pp 189-236
150. Loos M, Staal J, Pattij T, Smit AB, Spijker S (2012) Independent genetic loci for sensorimotor gating and attentional performance in BXD recombinant inbred strains. Genes Brain Behav 11:147-156
151. MacDonald SW, Cervenka S, Farde L, Nyberg L, Backman L (2009) Extrastriatal dopamine D2 receptor binding modulates intraindividual variability in episodic recognition and executive functioning. Neuropsychologia 47:2299-2304
152. Marquand AF, De Simoni S, O'Daly OG, Williams SC, Mourao-Miranda J, Mehta MA (2011) Pattern classification of working memory networks reveals differential effects of methylphenidate, atomoxetine, and placebo in healthy volunteers. Neuropsychopharmacology 36:1237-1247
153. Matsumoto M, Yoshioka M, Togashi H, Mori K, Ueno K, Saito H (1998) Effects of idazoxan on dopamine release in the prefrontal cortex of freely moving rats. Eur J Pharmacol 343:165-170
154. Maziade M, Rouleau N, Lee B, Rogers A, Davis L, Dickson R (2009) Atomoxetine and neuropsychological function in children with attention-deficit/hyperactivity disorder: results of a pilot study. J Child Adolesc Psychopharmacol 19:709-718
155. Mervaala E, Alhainen K, Helkala EL, Partanen J, Jousmaki V, Vayrynen M, Heinonen E, Riekkinen P (1993) Electrophysiological and neuropsychological effects of a central alpha 2-antagonist atipamezole in healthy volunteers. Behav Brain Res 55:85-91
156. Milstein JA, Dalley JW, Robbins TW (2010) Methylphenidate-induced impulsivity: pharmacological antagonism by beta-adrenoreceptor blockade. J Psychopharmacol 24:309-321
157. Modirrousta M, Fellows LK (2008) Dorsal medial prefrontal cortex plays a necessary role in rapid error prediction in humans. J Neurosci 28:14000-14005
158. Moron JA, Brockington A, Wise RA, Rocha BA, Hope BT (2002) Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci 22:389-395
159. Muller U, Clark L, Lam ML, Moore RM, Murphy CL, Richmond NK, Sandhu RS, Wilkins IA, Menon DK, Sahakian BJ, Robbins TW (2005) Lack of effects of guanfacine on executive and memory functions in healthy male volunteers. Psychopharmacol (Berl) 182:205-213
160. Nandam LS, Hester R, Wagner J, Cummins TD, Garner K, Dean AJ, Kim BN, Nathan PJ, Mattingley JB, Bellgrove MA (2010) Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability. Biol Psychiatry 69(9):902-904
161. Nandam LS, Hester R, Wagner J, Dean AJ, Messer C, Honeysett A, Nathan PJ, Bellgrove MA (2012) Dopamine D(2) receptor modulation of human response inhibition and error awareness. J Cogn Neurosci 25(4):649-656
162. Narayanan NS, Laubach M (2008) Neuronal correlates of post-error slowing in the rat dorsomedial prefrontal cortex. J Neurophysiol 100:520-525
163. Narayanan NS, Horst NK, Laubach M (2006) Reversible inactivations of rat medial prefrontal cortex impair the ability to wait for a stimulus. Neuroscience 139:865-876
164. Navarra R, Graf R, Huang Y, Logue S, Comery T, Hughes Z, Day M (2008) Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Prog Neuropsychopharmacol Biol Psychiatry 32:34-41
165. Nayak S, Cassaday HJ (2003) The novel dopamine D4 receptor agonist (PD 168,077 maleate): doses with different effects on locomotor activity are without effect in classical conditioning. Prog Neuropsychopharmacol Biol Psychiatry 27:441-449
166. Newman-Tancredi A, Audinot-Bouchez V, Gobert A, Millan MJ (1997) Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors. Eur J Pharmacol 319:379-383
167. Nieuwenhuis S, Ridderinkhof KR, Talsma D, Coles MG, Holroyd CB, Kok A, van der Molen MW (2002) A computational account of altered error processing in older age: dopamine and the error-related negativity. Cogn Affect Behav Neurosci 2:19-36
168. Oades RD (1987) Attention deficit disorder with hyperactivity (ADDH): the contribution of catecholaminergic activity. Prog Neurobiol 29:365-391
169. Oak JN, Oldenhof J, Van Tol HH (2000) The dopamine D(4) receptor: one decade of research. Eur J Pharmacol 405:303-327
170. O'Connell RG, Bellgrove MA, Dockree PM, Lau A, Hester R, Garavan H, Fitzgerald M, Foxe JJ, Robertson IH (2009) The neural correlates of deficient error awareness in attention-deficit hyperactivity disorder (ADHD). Neuropsychologia 47:1149-1159
171. Overtoom CC, Kenemans JL, Verbaten MN, Kemner C, van der Molen MW, van Engeland H, Buitelaar JK, Koelega HS (2002) Inhibition in children with attention-deficit/hyperactivity disorder: a psychophysiological study of the stop task. Biol Psychiatry 51:668-676
172. Pan WH, Yang SY, Lin SK (2004) Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex. Synapse 53:44-52
173. Passetti F, Levita L, Robbins TW (2003) Sulpiride alleviates the attentional impairments of rats with medial prefrontal cortex lesions. Behav Brain Res 138:59-69
174. Pattij T, Janssen MC, Vanderschuren LJ, Schoffelmeer AN, van Gaalen MM (2007) Involvement of dopamine D1 and D2 receptors in the nucleus accumbens core and shell in inhibitory response control. Psychopharmacol (Berl) 191:587-598
175. Pattij T, Schetters D, Schoffelmeer AN, van Gaalen MM (2012) On the improvement of inhibitory response control and visuospatial attention by indirect and direct adrenoceptor agonists. Psychopharmacol (Berl) 219:327-340
176. Perry GM, Sagvolden T, Faraone SV (2010a) Intra-individual variability in genetic and environmental models of attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 153B:1094-1101
177. Perry GM, Sagvolden T, Faraone SV (2010b) Intraindividual variability (IIV) in an animal model of ADHD - the spontaneously hypertensive rat. Behav Brain Funct 6:56
178. Pertovaara A, Haapalinna A, Sirvio J, Virtanen R (2005) Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist. CNS Drug Rev 11:273-288
179. Pezze MA, Dalley JW, Robbins TW (2007) Differential roles of dopamine D1 and D2 receptors in the nucleus accumbens in attentional performance on the five-choice serial reaction time task. Neuropsychopharmacology 32:273-283
180. Picton TW, Stuss DT, Alexander MP, Shallice T, Binns MA, Gillingham S (2007) Effects of focal frontal lesions on response inhibition. Cereb Cortex 17:826-838
181. Pilla M, Perachon S, Sautel F, Garrido F, Mann A, Wermuth CG, Schwartz JC, Everitt BJ, Sokoloff P (1999) Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature 400:371-375
182. Puumala T, Riekkinen P Sr, Sirvio J (1997) Modulation of vigilance and behavioral activation by alpha-1 adrenoceptors in the rat. Pharmacol Biochem Behav 56:705-712
183. Rabbitt PM (1966) Errors and error correction in choice-response tasks. J Exp Psychol 71:264-272
184. Rabbitt P, Rodgers B (1977) What does a man do after he makes an error? An analysis of response programming. Q J Exp Psychol 29:727-743
185. Rama P, Linnankoski I, Tanila H, Pertovaara A, Carlson S (1996) Medetomidine, atipamezole, and guanfacine in delayed response performance of aged monkeys. Pharmacol Biochem Behav 55:415-422
186. Ridderinkhof KR, Ullsperger M, Crone EA, Nieuwenhuis S (2004) The role of the medial frontal cortex in cognitive control. Science 306:443-447
187. Robbins TW (2002) The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacol (Berl) 163:362-380
188. Robbins TW, Arnsten AF (2009) The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 32:267-287
189. Robinson ES, Eagle DM, Mar AC, Bari A, Banerjee G, Jiang X, Dalley JW, Robbins TW (2008) Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 33:1028-1037
190. Rommelse NN, Altink ME, Oosterlaan J, Beem L, Buschgens CJ, Buitelaar J, Sergeant JA (2008) Speed, variability, and timing of motor output in ADHD: which measures are useful for endophenotypic research? Behav Genet 38:121-132
191. Rowe JB, Saunders JR, Durantou F, Robbins TW (1996) Systemic idazoxan impairs performance in a non-reversal shift test: implications for the role of the central noradrenergic systems in selective attention. J Psychopharmacol 10:188-194
192. Rubia K, Smith AB, Brammer MJ, Toone B, Taylor E (2005) Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD. Am J Psychiatry 162:1067-1075
193. Russell VA, Oades RD, Tannock R, Killeen PR, Auerbach JG, Johansen EB, Sagvolden T (2006) Response variability in attention-deficit/hyperactivity disorder: a neuronal and glial energetics hypothesis. Behav Brain Funct 2:30
194. Sabol KE, Richards JB, Broom SL, Roach JT, Hausknecht K (2003) Effects of stimulus salience and methamphetamine on choice reaction time in the rat: central tendency versus distribution skew. Behav Pharmacol 14:489-500
195. Sahakian BJ, Coull JJ, Hodges JR (1994) Selective enhancement of executive function by idazoxan in a patient with dementia of the frontal lobe type. J Neurol Neurosurg Psychiatry 57:120-121
196. Sautel F, Griffon N, Sokoloff P, Schwartz JC, Launay C, Simon P, Costentin J, Schoenfelder A, Garrido F, Mann A et al (1995) Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents. J Pharmacol Exp Ther 275:1239-1246
197. Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E, Arnsten AF, Cohen DJ, Leckman JF (2001) A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 158:1067-1074
198. Scatton B (1977) Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration. Eur J Pharmacol 46:363-369
199. Schachar R, Tannock R, Marriott M, Logan G (1995) Deficient inhibitory control in attention deficit hyperactivity disorder. J Abnorm Child Psychol 23:411-437
200. Schachar RJ, Chen S, Logan GD, Ornstein TJ, Crosbie J, Ickowicz A, Pakulak A (2004) Evidence for an error monitoring deficit in attention deficit hyperactivity disorder. J Abnorm Child Psychol 32:285-293
201. Scheinin H, MacDonald E, Scheinin M (1988) Behavioural and neurochemical effects of antipamezole, a novel alpha 2-adrenoceptor antagonist. Eur J Pharmacol 151:35-42
202. Selken J, Nichols DE (2007) Alpha1-adrenergic receptors mediate the locomotor response to systemic administration of (+/-)-3,4- methylenedioxymethamphetamine (MDMA) in rats. Pharmacol Biochem Behav 86:622-630
203. Sesack SR, Hawrylak VA, Guido MA, Levey AI (1998) Cellular and subcellular localization of the dopamine transporter in rat cortex. Adv Pharmacol 42:171-174
204. Sibley DR, Strasser RH, Benovic JL, Daniel K, Lefkowitz RJ (1986) Phosphorylation/dephosphorylation of the beta-adrenergic receptor regulates its functional coupling to adenylate cyclase and subcellular distribution. Proc Natl Acad Sci U S A 83:9408-9412
205. Sidhu A, van Oene JC, Dandridge P, Kaiser C, Kebabian JW (1986) [125I]SCH 23982: the ligand of choice for identifying the D-1 dopamine receptor. Eur J Pharmacol 128:213-220
206. Sirvio J, MacDonald E (1999) Central alpha1-adrenoceptors: their role in the modulation of attention and memory formation. Pharmacol Ther 83:49-65
207. Sirvio J, Jakala P, Mazurkiewicz M, Haapalinna A, Riekkinen P Jr, Riekkinen PJ (1993) Dose- and parameter-dependent effects of atipamezole, an alpha 2-antagonist, on the performance of rats in a five-choice serial reaction time task. Pharmacol Biochem Behav 45:123-129
208. Smalley SL, Bailey JN, Palmer CG, Cantwell DP, McGough JJ, Del'Homme MA, Asarnow JR, Woodward JA, Ramsey C, Nelson SF (1998) Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Mol Psychiatry 3:427-430
209. Smith A, Nutt D (1996) Noradrenaline and attention lapses. Nature 380:291
210. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347:146-151
211. Solanto MV, Abikoff H, Sonuga-Barke E, Schachar R, Logan GD, Wigal T, Hechtman L, Hinshaw S, Turkel E (2001) The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: a supplement to the NIMH multimodal treatment study of AD/HD. J Abnorm Child Psychol 29:215-228
212. Sorge RE, Clarke PB (2009) Rats self-administer intravenous nicotine delivered in a novel smoking-relevant procedure: effects of dopamine antagonists. J Pharmacol Exp Ther 330:633-640
213. Spencer SV, Hawk LW Jr, Richards JB, Shiels K, Pelham WE Jr, Waxmonsky JG (2009) Stimulant treatment reduces lapses in attention among children with ADHD: the effects of methylphenidate on intra-individual response time distributions. J Abnorm Child Psychol 37:805-816
214. St Onge JR, Floresco SB (2009) Dopaminergic modulation of risk-based decision making. Neuropsychopharmacology 34:681-697
215. Stanwood GD, Artymyshyn RP, Kung MP, Kung HF, Lucki I, McGonigle P (2000) Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals. J Pharmacol Exp Ther 295:1223-1231
216. Stone EA, Quartermain D (1999) Alpha-1-noradrenergic neurotransmission, corticosterone, and behavioral depression. Biol Psychiatry 46:1287-1300
217. Strange BA, Dolan RJ (2007) Beta-adrenergic modulation of oddball responses in humans. Behav Brain Funct 3:29
218. Sun H, Green TA, Theobald DE, Birnbaum SG, Graham DL, Zeeb FD, Nestler EJ, Winstanley CA (2010) Yohimbine increases impulsivity through activation of cAMP response element binding in the orbitofrontal cortex. Biol Psychiatry 67:649-656
219. Swann AC, Birnbaum D, Jagar AA, Dougherty DM, Moeller FG (2005) Acute yohimbine increases laboratory-measured impulsivity in normal subjects. Biol Psychiatry 57:1209-1211
220. Swann AC, Lijffijt M, Lane SD, Cox B, Steinberg JL, Moeller FG (2013) Norepinephrine and impulsivity: effects of acute yohimbine. Psychopharmacology (Berl)
221. Swick D, Turken AU (2002) Dissociation between conflict detection and error monitoring in the human anterior cingulate cortex. Proc Natl Acad Sci U S A 99:16354-16359
222. Szabo ST, Blier P (2001) Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons. Eur J Neurosci 13:2077-2087
223. Szarfman A, Doraiswamy PM, Tonning JM, Levine JG (2006) Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database. Arch Neurol 63:299-300, author reply 300
224. Tanda G, Pontieri FE, Frau R, Di Chiara G (1997) Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 9:2077-2085
225. Tannock R, Schachar RJ, Carr RP, Chajczyk D, Logan GD (1989) Effects of methylphenidate on inhibitory control in hyperactive children. J Abnorm Child Psychol 17:473-491
226. Tannock R, Schachar R, Logan G (1995) Methylphenidate and cognitive flexibility: dissociated dose effects in hyperactive children. J Abnorm Child Psychol 23:235-266
227. Taylor FB, Russo J (2001) Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 21:223-228
228. Teicher MH, Lowen SB, Polcari A, Foley M, McGreenery CE (2004) Novel strategy for the analysis of CPT data provides new insight into the effects of methylphenidate on attentional states in children with ADHD. J Child Adolesc Psychopharmacol 14:219-232
229. Thierry AM, Blanc G, Sobel A, Stinus L, Golwinski J (1973) Dopaminergic terminals in the rat cortex. Science 182:499-501
230. Thierry AM, Le Douarin C, Penit J, Ferron A, Glowinski J (1986) Variation in the ability of neuroleptics to block the inhibitory influence of dopaminergic neurons on the activity of cells in the rat prefrontal cortex. Brain Res Bull 16:155-160
231. van Gaalen MM, Brueggeman RJ, Bronius PF, Schoffelmeer AN, Vanderschuren LJ (2006) Behavioral disinhibition requires dopamine receptor activation. Psychopharmacol (Berl) 187:73-85
232. van Wyk GW, Hazell PL, Kohn MR, Granger RE, Walton RJ (2012) How oppositionality, inattention, and hyperactivity affect response to atomoxetine versus methylphenidate: a pooled meta-analysis. J Atten Disord 16:314-324
233. Vaurio RG, Simmonds DJ, Mostofsky SH (2009) Increased intra-individual reaction time variability in attention-deficit/hyperactivity disorder across response inhibition tasks with different cognitive demands. Neuropsychologia 47:2389-2396
234. Verbruggen F, Logan GD (2008) Response inhibition in the stop-signal paradigm. Trends Cogn Sci 12:418-424
235. Virtanen R (1989) Pharmacological profiles of medetomidine and its antagonist, atipamezole. Acta Vet Scand Suppl 85:29-37
236. Virtanen R, Savola JM, Saano V (1989) Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole. Arch Int Pharmacodyn Ther 297:190-204
237. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F (2007) Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol 64:1575-1579
238. Vorel SR, Ashby CR Jr, Paul M, Liu X, Hayes R, Hagan JJ, Middlemiss DN, Stemp G, Gardner EL (2002) Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 22:9595-9603
239. Wardle MC, Yang A, de Wit H (2012) Effect of d-amphetamine on post-error slowing in healthy volunteers. Psychopharmacol (Berl) 220:109-115
240. Wilens TE (2008) Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 28:S46-S53
241. Yamamoto BK, Novotney S (1998) Regulation of extracellular dopamine by the norepinephrine transporter. J Neurochem 71:274-280
242. Young JW, Powell SB, Scott CN, Zhou X, Geyer MA (2011) The effect of reduced dopamine D4 receptor expression in the 5-choice continuous performance task: separating response inhibition from premature responding. Behav Brain Res 222:183-192
243. Zhang K, Davids E, Tarazi FI, Baldessarini RJ (2002) Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions. Psychopharmacol (Berl) 161:100-106
244. Zhang K, Grady CJ, Tsapakis EM, Andersen SL, Tarazi FI, Baldessarini RJ (2004) Regulation of working memory by dopamine D4 receptor in rats. Neuropsychopharmacology 29:1648-1655
245. Zirnheld PJ, Carroll CA, Kieffaber PD, O'Donnell BF, Shekhar A, Hetrick WP (2004) Haloperidol impairs learning and error-related negativity in humans. J Cogn Neurosci 16:1098-1112